POU5F1 and embryonal carcinoma: To assess the effect of dual inhibiting AKT and OCT4, human embryonal carcinoma NCCIT cells were first infected with an OCT4 shRNA lentivirus (sh-OCT4), followed by Akti-1/2 treatment.